Viela Bio, Inc. (36) | Uncategorized (9)
Recent Contracts
-
Form of Tender and Support Agreement
(Filed With SEC on February 1, 2021)
-
Description of Securities
(Filed With SEC on March 25, 2020)
-
Offer Letter, by and between the Registrant and Mitchell Chan, dated August 15, 2018
(Filed With SEC on August 29, 2019)
-
Offer Letter, by and between the Registrant and William Ragatz, dated November 27, 2018
(Filed With SEC on August 29, 2019)
-
BioWa Sublicense Agreement, by and between the Registrant and MedImmune, LLC, dated as of February 23, 2018
(Filed With SEC on August 29, 2019)
-
Supplemental Agreement dated as of August 14, 2018, by and between SBI Biotech Co. Ltd. and the Registrant
(Filed With SEC on August 29, 2019)
-
BioWa/Lonza Sublicense Agreement, by and between the Registrant and MedImmune, LLC, dated as of February 23, 2018
(Filed With SEC on August 29, 2019)
-
Lonza Sublicense Agreement, by and between the Registrant and MedImmune, LLC, dated as of February 23, 2018
(Filed With SEC on August 29, 2019)
-
Medical Research Council Payment Agreement, by and between the Registrant and MedImmune Limited, dated February 23, 2018
(Filed With SEC on August 29, 2019)